companydata.dkcompanydata.dk

UNIKUM Therapeutics ApS: Financial statements 2025

CVR: 41192925

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

UNIKUM Therapeutics ApS (CVR 41192925) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -247,887 and a net result of DKK -859,076 compared with DKK -13,797,011 the year before. Equity in the 2025 report amounted to DKK -5,680,033.

Gross Profit
DKK -247,887
Profit/Loss
DKK -859,076
Equity
DKK -5,680,033
Total Assets
DKK 137,899
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--248K-859K-5.7M0
2024--7.4M-13.8M-4.8M9
2023--7.5M-14.9M-16.3M9
2022--3.3M-7.6M-15.3M7
2021--2.7M-5.6M-7.6M5

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is UNIKUM Therapeutics ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

UNIKUM Therapeutics ApS: The 2024 annual report is outMay 27, 2025

UNIKUM Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -7,368,177, and the net result was DKK -13,797,011.

Nebojsa Milovic leaves the board of UNIKUM Therapeutics ApSMay 27, 2025

As of May 27, 2025, Nebojsa Milovic has left the board of directors of UNIKUM Therapeutics ApS.

Margo Rosemary Roberts leaves the board of UNIKUM Therapeutics ApSMay 27, 2025

As of May 27, 2025, Margo Rosemary Roberts has left the board of directors of UNIKUM Therapeutics ApS.

About UNIKUM Therapeutics ApS

UNIKUM Therapeutics ApS is a Danish company of the type Anpartsselskab based in Risskov, founded in 2020. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Martin Roelsgaard Jakobsen. The board consists of Ulrik Bjerl Nielsen (chair), Martin Roelsgaard Jakobsen and Stefan Wildt. The company's owners include MEDIC ADVICE ApS, MR Jakobsen Holding ApS and BII Holdings A/S. The company has 2 employees (2025). In 2025, the company reported a gross profit of DKK -247,887 and a net result of DKK -859,076 compared with DKK -13,797,011 the year before. Equity in the 2025 report amounted to DKK -5,680,033.

Source: annual report 2025, Danish Business Authority

Other financial years